colchicine has been researched along with Chronic Disease in 143 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (26.57) | 18.7374 |
| 1990's | 16 (11.19) | 18.2507 |
| 2000's | 29 (20.28) | 29.6817 |
| 2010's | 34 (23.78) | 24.3611 |
| 2020's | 26 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Alyasin, S; Babaeian, M; Esmaeilzadeh, H; Mortazavifar, N; Nabavizadeh, SH | 1 |
| Dominati, A; Meyer, P; Seebach, JD | 1 |
| Delmas, C; Roubille, C; Roubille, F | 1 |
| Abe, N; Bohgaki, M; Kasahara, H | 1 |
| Bax, WA; Budgeon, CA; Cornel, JH; Eikelboom, JW; El Messaoudi, S; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Prins, FJ; Ronner, E; Schut, A; Thompson, PL; Tijssen, JGP | 1 |
| Chen, HC; Wei, JC; Yang, DH | 1 |
| Demirkaya, E; Glazer, S; Karp, N; Richard, K | 1 |
| Fiegen, N; Malik, MN; Petrasko, M; Saad Shaukat, MH | 1 |
| Cauchon, M; Dussault, C; Huard, G; Lanthier, L; Plourde, MÉ | 2 |
| Inoue, N; Kaneko, S; Mizuta, M; Shimizu, M; Yachie, A | 1 |
| Adler, Y; Andreis, A; Brucato, A; De Ferrari, GM; Imazio, M | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Alings, M; Bax, WA; Budgeon, CA; Cornel, JH; Dirksen, M; Eikelboom, JW; Fiolet, ATL; Hankey, GJ; Hendriks, R; Hoogslag, P; Ireland, MA; Jerzewski, A; Judkins, C; Kuijper, AFM; Latchem, D; Lenderink, T; Morton, A; Mosterd, A; Nidorf, SM; Nierop, P; Opstal, TSJ; Saklani, P; Schaap, J; Schut, A; Swart, H; Tan, I; The, SHK; Thompson, AG; Thompson, PL; Tijssen, JGP; van Hessen, MWJ; Whelan, A; Xu, XF | 1 |
| Bax, WA; Cornel, JH; de Kleijn, D; Fiolet, ATL; Mosterd, A; Opstal, TSJ; Silvis, MJM; van der Horst, FAL | 1 |
| Brasnu, D; Katz, P; Mailly, M; Majer, J; Sené, T | 1 |
| Liuzzo, G; Patrono, C | 1 |
| Cohn, JN | 1 |
| Ismail, TF; Pooni, RS | 1 |
| Jackson, CD; Kaiser, D | 1 |
| Gebhard, C; Regitz-Zagrosek, V | 1 |
| Fischer, BG | 1 |
| Javor, E; Lucijanic, M; Skelin, M | 1 |
| D'Amario, D; Galli, M; Rodolico, D | 1 |
| Cornel, JH; Fiolet, ATL; Thompson, PL | 1 |
| Davidson, BR; Eusebi, LH; Gurusamy, KS; Saffioti, F; Thorburn, D; Tsochatzis, E | 1 |
| Choi, SY; Ham, YR; Lee, YM; Park, MH; Suh, KS; Yeo, MK | 1 |
| Hondebrink, LLC; Opstelten, W | 1 |
| Brogan, PA; Cantarini, L; Cimaz, R; Eijkelboom, C; Fingerhutová, S; Frenkel, J; Gattorno, M; Hofer, M; Iagaru, N; Insalaco, A; Jelusic, M; Kone-Paut, I; Licciardi, F; Modesto, C; Nielsen, S; Nikishina, I; Olivieri, AN; Papa, R; Papadopoulou-Alataki, E; Ruperto, N; Stanevica, V; Susic, G; Ter Haar, NM; Uziel, Y; van Gijn, M; Vitale, A | 1 |
| ARCANGELI, P; COMI, G; FERRARI LELLI, G | 1 |
| Alexopoulos, D; Angelidis, C; Bouras, G; Cleman, MW; Deftereos, S; Giannopoulos, G; Kaoukis, A; Karageorgiou, S; Kossyvakis, C; Manolis, AS; Pagoni, S; Panagopoulou, V; Papadimitriou, C; Pyrgakis, V; Raisakis, K; Stefanadis, C; Vastaki, M | 1 |
| Dalbeth, N; Lauterio, TJ; Wolfe, HR | 1 |
| Akar, T; Dindar, G | 1 |
| Bombardier, C; Buchbinder, R; Edwards, CJ; Kydd, AS; Seth, R | 1 |
| FitzGerald, J; Khanna, PP | 1 |
| Allali, S; Bodemer, C; Chalumeau, M; Fraitag, S; Terrier, B | 1 |
| Bachmeyer, C; Girot, R; Moguelet, P; Rein, C | 1 |
| Avram, A; Duarte, C; Papagoras, C; Ritis, K; Santos, MJ; Scarpioni, R; Schmidt, WA; Skendros, P | 1 |
| Hart, PA; Nemer, LC; Yearsley, MM | 1 |
| Bessis, D; Croci-Torti, A; Guillot, B; Rigau, V | 1 |
| Rockey, DC | 2 |
| Andrade, SE; Briesacher, B; Fouayzi, H; Harrold, LR; Ockene, IS; Raebel, MA; Yood, RA | 1 |
| Donghi, D; Mainetti, C | 1 |
| Albertini, F; Ballardini, G; Bassi, P; Briganti, E; Casadio, C; Casolari, S; De Angelis, P; De Donà, D; Gaddoni, G; Menni, B; Patrizi, A; Savoia, F; Spadola, G; Zanotti, M | 1 |
| Goh, EM; Gun, SC; Yeap, SS | 1 |
| Schlesinger, N | 2 |
| Rao, SS; Singh, S | 1 |
| Quillen, DM | 1 |
| Graser, E; Pope, RS; Zychowicz, ME | 1 |
| Ben-Zvi, I; Livneh, A | 1 |
| Akyuz, S; Ergelen, M; Uyarel, H; Yaylak, B | 1 |
| Khanna, D; Khanna, PP; Maranian, P; Perez-Ruiz, F | 1 |
| Davis, MW; Lauterio, TJ; Wertheimer, AI | 1 |
| Larrimore, C | 1 |
| Edelman, J; Tran, AP | 1 |
| Intong, LR; Murrell, DF | 1 |
| Eliason, MJ; Hull, CM; Pho, LN; Powell, DL; Regruto, M | 1 |
| Cagiano, R; Dipalma, G; Inchingolo, AD; Inchingolo, AM; Inchingolo, F; Marrelli, M; Podo Brunetti, S; Tarullo, A; Tatullo, M | 1 |
| Avhad, G; Dandale, A; Dhurat, R; Ghate, S | 1 |
| Cohen, JM; Dimitrakoff, JD; Fagin, AP; Hariton, E; Jackson, JL; Kuriyama, A; Niska, JR; Pierce, MW; Whelan, JS | 1 |
| Goh, LH; How, CH; Teng, GG; Tong, CY | 1 |
| Arendt-Nielsen, L; Fan, ZZ; Ge, HY; Jiang, H; Wei, H; Yao, W; Yue, SW; Zhang, Y | 1 |
| Elston, DM; George, R; Ritter, S; Serwatka, LM | 1 |
| Davis, RH; Eaker, EY; Gordon, JM; Robinson, ME; Sninksy, CA; Verne, GN | 1 |
| KELLNER, B; MATKO, L | 1 |
| CATTANEO, I; MANNINO-SIGILLO, A; VERCILLO, L | 2 |
| TALBOTT, JH | 1 |
| KONIGSBAUER, H | 1 |
| Conraads, V; Debie, K; Vrints, C | 1 |
| LAMBERS, K | 1 |
| Ameratunga, R; Casey, P; Lane, M | 1 |
| Benninger, J; Blassneck, K; Hahn, EG; Harsch, IA; Nusko, G | 1 |
| Abel, MP; Alloway, JA; Borstad, GC; Bryant, LR; Harris, MD; Scroggie, DA | 1 |
| Hda, A; Karim Moudden, M; Niamane, R; Zyani, M | 1 |
| Wong, ML | 1 |
| Cannella, AC; Mikuls, TR | 1 |
| Ah-Chan, JJ; Bevin, TH; Molteno, AC | 1 |
| Cantatore, FP; Corrado, A; D'Onofrio, F; Melillo, N; Santoro, N | 1 |
| Gilliland, WR; Keith, MP | 1 |
| Almagro, M; del Pozo, J; Fonseca, E; Malmierca, NM; Martín, CG; Martínez, W; Yebra-Pimentel, MT | 1 |
| Doherty, M; Roddy, E; Zhang, W | 1 |
| Cameron, JS; Doherty, M; Hingorani, A; Jaques, R; Jordan, KM; Nuki, G; Seckl, J; Snaith, M; Zhang, W | 1 |
| Petersel, D; Schlesinger, N | 1 |
| Criado, PR; Criado, RF; Martins, JE; Michalany, NS; Valente, NY; Vasconcellos, C | 1 |
| Paumgartner, G | 1 |
| Ichiba, S; Kanaji, K; Okuma, M; Sensaki, S; Sugiyama, T; Uchino, H | 1 |
| Spillotis, TE | 1 |
| Kochubeĭ, LN; Tatevosian, KG; Vinogradova, OM | 1 |
| Craig, MH; Hauser, CJ; Poole, GV | 1 |
| Gerteis, C; Kommerell, B; Plachky, J; Raedsch, R; Rudi, J; Sabouraud, A; Scherrmann, JM; Schlenker, T; Walter-Sack, I | 1 |
| Danziger, Y; Hodak, E; Mimouni, M; Mukamel, M; Zeharia, A | 1 |
| Barash, J; Cooper, M | 1 |
| Chu, CM; Liaw, YF; Lin, DY; Sheen, IS | 1 |
| Majeed, HA; Rawashdeh, M | 1 |
| al-Suwaid, AR; Banodkar, DD | 1 |
| Davis, RH; Eaker, EY; Sninsky, CA; Verne, GN | 1 |
| Adler, Y; Assali, A; Bayes de Luna, A; Bayes-Genis, A; Finkelstein, Y; Guindo, J; Khouri, A | 1 |
| Shimazaki, J; Shimmura, S; Tsubota, K; Yang, HY | 1 |
| Aguirre-Cruz, L; Calvillo, M; Sotelo, J | 1 |
| Caspi, A; Goland, S; Malnick, SD | 1 |
| Padeh, S; Passwell, JH | 1 |
| Langevitz, P; Livneh, A | 1 |
| Maisch, B; Ristić, AD; Seferovic, PM | 1 |
| Beutler, A; Clayburne, G; Eisner, E; Li-Yu, J; Rull, M; Schumacher, HR; Sieck, M | 1 |
| Disdier, P; Ene, N; Granel, B; Habib, G; Mesana, T; Pache, X; Rey, J; Serratrice, J; Swiader, L; Weiller, PJ | 1 |
| Gorter, KJ; Romeijnders, AC | 1 |
| Adle-Biassette, H; Aslangul-Castier, E; Lelievre, JD; Papo, T; Ranque-Francois, B | 1 |
| Emmerson, BT | 1 |
| Haire, M; McMillan, SA | 1 |
| Mangini, RJ | 1 |
| Bole, GG; Taborn, J; Thompson, GR | 1 |
| Kaidbey, KH; Kligman, AM; Petrozzi, JW | 1 |
| Böhm, R; Hägel, J; Maurin, N; Stefanidis, I | 1 |
| Reichen, J | 1 |
| Asherson, RA; Buchanan, N; Fletcher, CM; Hughes, GR; Kenwright, S | 1 |
| Garty, MS; Greif, J; Ilfeld, DN; Kivity, S; Schlesinger, M; Schwarz, YA; Topilsky, M | 1 |
| Ishige, Y; Iwatsubo, T; Mannen, T; Nukina, N | 1 |
| Guillén, A; Isanta, C; Izquierdo, C; Vallés, C; Vecino, R | 1 |
| Kaplan, MM | 1 |
| Barnes, RD; Folb, PI; Livingstone, RR; Sarembock, LA | 1 |
| Schneider, W; Wehmeier, A | 1 |
| Amaya, A; Mourelle, M; Rojkind, M; Yahuaca, P | 1 |
| Duncan, G; Kuncl, RW | 1 |
| German, DC; Holmes, EW | 1 |
| Koide, N; Koyama, T; Matsuo, N; Matsuo, T; Nakayama, T; Tsuji, T | 1 |
| af Ekenstam, E; Callen, JP | 1 |
| Brandenberg, J; Käppeli, R; Kissling, R; Papandreou, A | 1 |
| Crosby, TW; DiBartolomeo, AG; Gutmann, L; Riggs, JE; Schochet, SS | 1 |
| Cantin, A; Crystal, RG | 1 |
| Durkalec, J; Kościński, R | 1 |
| Ball, GV; Freeman, D | 1 |
| Häntzschel, H; Otto, W | 1 |
| Ravera, M | 1 |
| Mikkelsen, WM; Robinson, WD | 1 |
| Gottesbüren, H; Strohmeyer, G | 1 |
| Boschi, S; Dubravcić, M; Matusan, J; Tukić, A | 1 |
| Yu, TF | 1 |
| Burtonboy, G; Michotte, JL | 1 |
| Scott, JT | 1 |
31 review(s) available for colchicine and Chronic Disease
| Article | Year |
|---|---|
[Idiopathic recurrent pericarditis: review of the literature and the Geneva experience].
Topics: Aspirin; Chronic Disease; Colchicine; Humans; Pericarditis; Recurrence | 2022 |
Chronic recurrent multifocal osteomyelitis with myositis: A case report and review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Chronic Disease; Colchicine; Female; Hip; Humans; Ibuprofen; Magnetic Resonance Imaging; Muscle, Skeletal; Myositis; Osteomyelitis; Pamidronate; Recurrence; Treatment Outcome | 2020 |
Colchicine for acute and chronic coronary syndromes.
Topics: Acute Coronary Syndrome; Animals; Anti-Inflammatory Agents; Chronic Disease; Colchicine; Coronary Artery Disease; Humans; Treatment Outcome | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Topics: Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Chronic Disease; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mitochondria; Network Meta-Analysis; Penicillamine; Quality of Life; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
Recurrent AA Amyloidosis Combined With Chronic Active Antibody-mediated Rejection After Kidney Transplantation.
Topics: Amyloidosis; Biopsy; Chronic Disease; Colchicine; Female; Graft Rejection; HLA-DR Serological Subtypes; Humans; Immunohistochemistry; Immunosuppressive Agents; Isoantibodies; Kidney Diseases; Kidney Transplantation; Middle Aged; Plasmapheresis; Recurrence; Rituximab; Treatment Outcome | 2017 |
Mechanism of action of colchicine in the treatment of gout.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Colchicine; Gout; Gout Suppressants; Humans | 2014 |
Allopurinol for chronic gout.
Topics: Allopurinol; Benzbromarone; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Probenecid; Randomized Controlled Trials as Topic; Thiazoles; Uric Acid | 2014 |
Evolution of management of gout: a comparison of recent guidelines.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Gout; Gout Suppressants; Humans; Medication Adherence; Practice Guidelines as Topic | 2015 |
Current and future anti-fibrotic therapies for chronic liver disease.
Topics: Angiotensin II; Chronic Disease; Colchicine; Collagen; Extracellular Matrix; Hepatic Stellate Cells; Humans; Interferon-gamma; Ligands; Liver Cirrhosis; PPAR gamma; Pyridones | 2008 |
New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.
Topics: Acute Disease; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Polyethylene Glycols; Thiazoles; Urate Oxidase | 2010 |
Pharmacologic management of chronic constipation.
Topics: Alprostadil; Chronic Disease; Colchicine; Constipation; Guanylate Cyclase; Humans; Laxatives; Lubiprostone; Motilin; Narcotic Antagonists; Neurotrophin 3; Prebiotics; Probiotics; Receptors, Enterotoxin; Receptors, Guanylate Cyclase-Coupled; Receptors, Peptide; Surface-Active Agents | 2010 |
Crystal arthropathies: recognizing and treating "the gouch".
Topics: Allopurinol; Antimetabolites; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Probenecid; Thiazoles; Uric Acid; Uricosuric Agents | 2010 |
Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.
Topics: Biomarkers; Chronic Disease; Colchicine; Familial Mediterranean Fever; Gout Suppressants; Humans; Inflammation; Risk Factors; Serum Amyloid A Protein | 2011 |
A new perspective on the pharmacoeconomics of colchicine.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Chronic Disease; Colchicine; Costs and Cost Analysis; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; United States; Uric Acid | 2011 |
Management of epidermolysis bullosa acquisita.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoimmune Diseases; Chronic Disease; Colchicine; Collagen Type VII; Cyclosporine; Dapsone; Dermatologic Agents; Epidermolysis Bullosa Acquisita; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mycophenolic Acid; Photochemotherapy; Plasmapheresis; Rituximab; Sulfapyridine; Sulfasalazine | 2011 |
Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Chronic Disease; Chronic Pain; Colchicine; Humans; Male; MEDLINE; Mepartricin; Pelvic Pain; Prostatitis; Randomized Controlled Trials as Topic; Transcutaneous Electric Nerve Stimulation | 2012 |
The unwelcome visitor.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Gout; Humans; Male; Uric Acid | 2012 |
Management of acute and chronic gouty arthritis: present state-of-the-art.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Chronic Disease; Clinical Trials as Topic; Colchicine; Female; Gout Suppressants; Humans; Incidence; Male; Prevalence; Uricosuric Agents | 2004 |
Antifibrotic therapy in chronic liver disease.
Topics: Chronic Disease; Colchicine; Female; Humans; Interferon-gamma; Interleukin-10; Liver Cirrhosis; Liver Function Tests; Male; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Understanding treatments for gout.
Topics: Acute Disease; Adrenal Cortex Hormones; Behavior Therapy; Chronic Disease; Colchicine; Female; Gout; Gout Suppressants; Health Behavior; Humans; Hyperuricemia; Male; Practice Guidelines as Topic; Purines; Risk Factors; Uric Acid | 2005 |
Pathogenesis, clinical findings and management of acute and chronic gout.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Crystallization; Gout; Humans; Renal Insufficiency; Uric Acid | 2006 |
Updates in the management of gout.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Chronic Disease; Colchicine; Drug Therapy, Combination; Family Practice; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Pain Measurement; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Uric Acid | 2007 |
[Therapy of liver cirrhosis].
Topics: Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Colchicine; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Penicillamine; Propylthiouracil; Vidarabine | 1983 |
Diagnostic and treatment concerns in familial Mediterranean fever.
Topics: Amyloidosis; Animals; Arthritis; Chronic Disease; Colchicine; Diagnosis, Differential; DNA Mutational Analysis; Familial Mediterranean Fever; Humans; Muscular Diseases; Serositis; Vasculitis | 2000 |
[Is chronic or recurrent idiopathic pericarditis an autonomous inflammatory disease?].
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chronic Disease; Colchicine; Echocardiography; Electrocardiography; Female; Humans; Male; Middle Aged; Pericarditis; Platelet Aggregation Inhibitors; Recurrence | 2001 |
Drug control of gout and hyperuricaemia.
Topics: Allopurinol; Arthritis; Chronic Disease; Colchicine; Gout; Humans; Indomethacin; Naproxen; Phenylbutazone; Probenecid; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1978 |
[Drug treatment of cholestatic liver diseases].
Topics: Cholestasis, Intrahepatic; Chronic Disease; Colchicine; Humans; Immunosuppressive Agents; Liver Transplantation; Penicillamine; S-Adenosylmethionine; Ursodeoxycholic Acid | 1992 |
Hyperuricemia and gout.
Topics: Acute Disease; Adult; Allopurinol; Anti-Inflammatory Agents; Arthritis; Arthrography; Calcinosis; Chronic Disease; Colchicine; Female; Gout; Humans; Kidney Calculi; Kidney Diseases; Middle Aged; Probenecid; Uric Acid | 1986 |
Physiologic and biochemical basis for the treatment of gout and hyperuricemia.
Topics: Acute Disease; Adrenal Cortex Hormones; Arthritis; Chronic Disease; Colchicine; Glomerular Filtration Rate; Gout; Phenylbutazone; Purines; Urate Oxidase; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1969 |
[What is certain in gout therapy?].
Topics: Acute Disease; Allopurinol; Chronic Disease; Colchicine; Gout; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Kidney Tubules; Probenecid; Purines; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1971 |
15 trial(s) available for colchicine and Chronic Disease
| Article | Year |
|---|---|
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.
Topics: Aged; Chronic Disease; Colchicine; Coronary Disease; Heart Diseases; Humans; Myocardial Infarction | 2023 |
Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial.
Topics: Arthritis, Gouty; Chronic Disease; Colchicine; Gout; Gout Suppressants; Humans; Probenecid; Symptom Flare Up; Uric Acid | 2023 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Aged; Anti-Inflammatory Agents; Cardiovascular Diseases; Chronic Disease; Colchicine; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Intention to Treat Analysis; Male; Middle Aged; Proportional Hazards Models | 2020 |
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein.
Topics: Aged; Biomarkers; C-Reactive Protein; Chronic Disease; Colchicine; Coronary Artery Disease; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Inflammation; Leukocyte Count; Lipid Metabolism; Male; Middle Aged; Platelet Count; Prospective Studies; Treatment Outcome | 2020 |
Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study.
Topics: Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Chronic Disease; Colchicine; Double-Blind Method; Drug Administration Schedule; Exercise Tolerance; Female; Heart Failure; Humans; Interleukin-6; Kaplan-Meier Estimate; Length of Stay; Male; Prospective Studies; Treatment Outcome | 2014 |
Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Colchicine; Colon; Constipation; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebo Effect; Prospective Studies | 2003 |
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.
Topics: Arthritis, Gouty; Chronic Disease; Colchicine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Prospective Studies; Risk Assessment; Secondary Prevention; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2004 |
Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features.
Topics: Acetates; Adult; Anti-Infective Agents; Chronic Disease; Colchicine; Cyclopropanes; Dapsone; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Sulfides; Tubulin Modulators; Urticaria | 2008 |
A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients.
Topics: Adult; Aged; Chronic Disease; Colchicine; Female; Gout Suppressants; Hepatitis B; Humans; Liver Cirrhosis; Male; Middle Aged; Prospective Studies | 1996 |
Colchicine as a novel therapeutic agent in chronic bullous dermatosis of childhood.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Chronic Disease; Colchicine; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Male; Skin Diseases, Vesiculobullous | 1997 |
Colchicine is an effective treatment for patients with chronic constipation: an open-label trial.
Topics: Chronic Disease; Colchicine; Constipation; Drug Administration Schedule; Female; Gastrointestinal Transit; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies | 1997 |
Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
Topics: Allopurinol; Chronic Disease; Colchicine; Crystallization; Extracellular Space; Follow-Up Studies; Gout; Gout Suppressants; Humans; Knee Joint; Male; Prospective Studies; Treatment Outcome; Uric Acid | 2001 |
Topical colchicine therapy for recalcitrant psoriasis.
Topics: Administration, Topical; Chronic Disease; Colchicine; Drug Evaluation; Humans; Occlusive Dressings; Ointments; Psoriasis; Skin Absorption | 1975 |
A clinical and immunologic study of colchicine in asthma.
Topics: Adolescent; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Chronic Disease; Colchicine; Concanavalin A; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lung; Male; Randomized Controlled Trials as Topic; Skin Tests; T-Lymphocytes, Regulatory; Theophylline | 1990 |
98 other study(ies) available for colchicine and Chronic Disease
| Article | Year |
|---|---|
Efficacy of the colchicine add-on therapy in patients with autoimmune chronic urticaria.
Topics: Chronic Disease; Chronic Urticaria; Colchicine; Humans; Quality of Life; Urticaria | 2021 |
Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?
Topics: Chronic Disease; Colchicine; Humans; Interleukin 1 Receptor Antagonist Protein; Pericarditis; Recurrence | 2022 |
Dramatic improvement with colchicine in antihistamine- and omalizumab-resistant chronic spontaneous urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Colchicine; Histamine Antagonists; Histamine H1 Antagonists; Humans; Omalizumab; Treatment Outcome; Urticaria | 2022 |
A young woman with fever and polyserositis caused by familial Mediterranean fever.
Topics: Chronic Disease; Colchicine; Familial Mediterranean Fever; Female; Fever; Humans; Inflammation | 2023 |
Relapse of colchicine-intolerant, corticosteroid-dependent recurrent idiopathic pericarditis after perigestational discontinuation of anakinra: uncertain safety of anakinra in pregnancy and the need for shared decision-making.
Topics: Adrenal Cortex Hormones; Chronic Disease; Colchicine; COVID-19; Female; Humans; Infant, Newborn; Interleukin 1 Receptor Antagonist Protein; Pericarditis; Pregnancy; Recurrence | 2023 |
[In patients with recent myocardial infarction, is colchicine effective in preventing cardiovascular events with a safety profile equivalent to placebo?]
Topics: Adult; Aged; Cardiovascular Diseases; Chronic Disease; Colchicine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Positive Effects of Local Botulinum Toxin Injection and Colchicine for Complicated Chronic Recurrent Parotitis: A Case Report.
Topics: Adult; Botulinum Toxins; Botulinum Toxins, Type A; Chronic Disease; Colchicine; Female; Humans; Parotid Gland; Parotitis | 2021 |
Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2020 |
[In patients with stable chronic coronary disease, how effective is colchicine in preventing cardiovascular events and what are the adverse reactions when compared to placebo?]
Topics: Chronic Disease; Colchicine; Coronary Disease; Heart Diseases; Humans; Myocardial Infarction | 2020 |
Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Research in brief: Colchicine for chronic coronary disease: a recent randomised controlled trial.
Topics: Chronic Disease; Colchicine; Coronary Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease.
Topics: Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine in Patients with Chronic Coronary Disease. Reply.
Topics: Anti-Inflammatory Agents; Chronic Disease; Colchicine; Coronary Artery Disease; Heart Diseases; Humans | 2021 |
Colchicine for secondary prevention in chronic coronary disease?
Topics: Chronic Disease; Colchicine; Coronary Disease; Heart Diseases; Humans; Secondary Prevention | 2021 |
[A woman with a white skin lesion of her toe].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Chronic Disease; Colchicine; Female; Gout; Humans; Skin; Skin Diseases; Toes; Uric Acid | 2018 |
Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age of Onset; Antirheumatic Agents; Child; Child, Preschool; Chronic Disease; Colchicine; Europe; Female; Genetic Variation; Hereditary Autoinflammatory Diseases; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Pedigree; Registries; Retrospective Studies; Young Adult | 2019 |
[Behavior of intradermal reaction to colchicine in chronic tonsillitis before and after intervention].
Topics: Chronic Disease; Colchicine; Humans; Tonsillitis | 1950 |
A very rare cause of diarrhea: epidermolysis bullosa.
Topics: Adult; Chronic Disease; Colchicine; Diarrhea; Epidermolysis Bullosa; Gout Suppressants; Humans; Male | 2014 |
Efficacy of colchicine in a child with relapsing bullous Henoch-Schönlein purpura.
Topics: Child, Preschool; Chronic Disease; Colchicine; Humans; IgA Vasculitis; Male; Recurrence | 2016 |
Facial lesions heralding the onset and relapse of eosinophilic fasciitis.
Topics: Adult; Arthritis; Biopsy; Chronic Disease; Colchicine; Edema; Eosinophilia; Fascia; Fasciitis; Folic Acid; Humans; Male; Myalgia; Prednisone; Recurrence; Synovitis; Ursodeoxycholic Acid; Vitamin E; West Indies | 2016 |
Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Gouty; Chronic Disease; Colchicine; Comorbidity; Febuxostat; Gout Suppressants; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Male; Patient Selection; Prednisolone; Recurrence | 2015 |
An Unusual Cause of Chronic Nausea and Abdominal Pain.
Topics: Abdominal Pain; Aged; Biopsy; Chronic Disease; Colchicine; Duodenoscopy; Duodenum; Female; Gout Suppressants; Humans; Mitosis; Nausea | 2016 |
[Chronic recurrent annular neutrophilic dermatosis].
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Colchicine; Female; Forearm; Humans; Leg; Neck; Neutrophils; Skin Diseases; Treatment Outcome | 2017 |
The dynamics of chronic gout treatment: medication gaps and return to therapy.
Topics: Age Factors; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Chronic Disease; Cohort Studies; Colchicine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Gout; Gout Suppressants; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Patient Compliance; Probability; Proportional Hazards Models; Risk Assessment; Severity of Illness Index; Sex Factors; Time Factors; Treatment Outcome; Uric Acid | 2010 |
Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement.
Topics: Adolescent; Antibodies, Monoclonal; Arthritis; Aspirin; Azathioprine; Behcet Syndrome; Chronic Disease; Colchicine; HLA-B Antigens; HLA-B51 Antigen; Humans; Ileitis; Infliximab; Magnetic Resonance Imaging; Male; Prednisone; Retinal Vasculitis; Scrotum; Vasculitis, Central Nervous System | 2010 |
A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy.
Topics: Anti-Inflammatory Agents; Aspirin; Chronic Disease; Colchicine; Dermatologic Agents; Drug Therapy, Combination; Humans; Male; Methotrexate; Middle Aged; Pericarditis; Pleurisy; Psoriasis | 2010 |
A survey on the management of gout in Malaysia.
Topics: Acute Disease; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Cross-Sectional Studies; Cyclooxygenase 2 Inhibitors; Glucocorticoids; Gout; Gout Suppressants; Humans; Malaysia; Primary Health Care; Professional Practice; Reference Values; Surveys and Questionnaires; Uric Acid | 2009 |
The current state of care in gout: Addressing the need for better understanding of an ancient disease.
Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Chronic Disease; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Patient Education as Topic; Quality of Life; Risk Factors; Thiazoles; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2010 |
Transient constrictive pericarditis: an elusive diagnosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Echocardiography; Humans; Magnetic Resonance Imaging; Pericardiectomy; Pericarditis, Constrictive; Pericardium; Time Factors; Tomography, X-Ray Computed; Tubulin Modulators | 2010 |
Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout.
Topics: Aged; Chronic Disease; Cohort Studies; Colchicine; Disability Evaluation; Dose-Response Relationship, Drug; Female; Gout; Gout Suppressants; Health Surveys; Humans; Longitudinal Studies; Male; Middle Aged; Quality of Life; Treatment Outcome; Uric Acid | 2011 |
Chronic familial Mediterranean fever with development of secondary amyloidosis.
Topics: Adult; Amyloidosis; Chronic Disease; Colchicine; Familial Mediterranean Fever; Humans; Male; Young Adult | 2011 |
Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout.
Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Drug Resistance; Gout; Gout Suppressants; Humans; Injections, Subcutaneous; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Male; Middle Aged; Treatment Outcome | 2011 |
Treatment of chronic urticaria with colchicine.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Colchicine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urticaria | 2011 |
Combined occlusal and pharmacological therapy in the treatment of temporo-mandibular disorders.
Topics: Adult; Benzodiazepines; Chronic Disease; Colchicine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Nordazepam; Occlusal Splints; Pain; Pain Measurement; Temporomandibular Joint Disorders; Treatment Outcome | 2011 |
Unknown: Multiple painful nodules - what is the diagnosis? Chronic tophaceous gout.
Topics: Alcoholics; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Chronic Disease; Colchicine; Diabetes Mellitus; Drug Therapy, Combination; Gout; Gout Suppressants; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pain; Treatment Outcome; Uric Acid | 2011 |
Effects of colchicine-induced microtubule depolymerization on TRPV4 in rats with chronic compression of the dorsal root ganglion.
Topics: Animals; Cell Line; Cell Survival; Chronic Disease; Colchicine; Ganglia, Spinal; Humans; Hyperalgesia; Microtubules; Neuralgia; Patch-Clamp Techniques; Posterior Horn Cells; Radiculopathy; Rats; TRPV Cation Channels; Tubulin Modulators | 2013 |
Long-term suppression of chronic Sweet's syndrome with colchicine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Dapsone; Female; Glucocorticoids; Gout Suppressants; Humans; Middle Aged; Prednisone; Sweet Syndrome; Treatment Failure | 2002 |
[The effects of acute and chronic colchicine poisoning on the organs of the rat].
Topics: Animals; Chronic Disease; Colchicine; Drug-Related Side Effects and Adverse Reactions; Poisoning; Rats | 1953 |
[The liver in acute, subacute and chronic deacetylmethylcolchicine poisoning; histologic study in rabbit].
Topics: Animals; Antineoplastic Agents; Chronic Disease; Colchicine; Liver; Rabbits | 1955 |
[The kidney in acute, subacute and chronic experimental deacetylmethylcolchicine poisoning; histologic study in rabbit].
Topics: Animals; Antineoplastic Agents; Chronic Disease; Colchicine; Kidney; Rabbits | 1955 |
Selected aspects of acute and chronic gouty arthritis; an internist's interpretation of an orthopaedist's experiences with gout and gouty arthritis.
Topics: Arthritis, Gouty; Chronic Disease; Colchicine; Gout; Humans; Orthopedics; Probenecid | 1958 |
[Effect of chronic colchicine poisoning on experimental mycoses].
Topics: Chronic Disease; Colchicine; Drug-Related Side Effects and Adverse Reactions; Mycoses; Poisoning | 1955 |
Colchicine-induced rhabdomyolysis in a patient with chronic heart failure.
Topics: Biomarkers; Chronic Disease; Colchicine; Creatine Kinase; Creatinine; Gout; Gout Suppressants; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Rhabdomyolysis | 2003 |
[Organ changes in chronic colchicine poisoning].
Topics: Chronic Disease; Colchicine; Drug-Related Side Effects and Adverse Reactions; Humans | 1951 |
Familial Mediterranean fever: 36 years to diagnosis.
Topics: Abdominal Pain; Adult; Chronic Disease; Colchicine; Cytoskeletal Proteins; Emigration and Immigration; Familial Mediterranean Fever; Female; Humans; Jews; Mutation; New Zealand; Proteins; Pyrin | 2004 |
[Recurrent bouts of fever accompanied by abdominal pain and emesis].
Topics: Abdominal Pain; Adult; Amyloid Neuropathies; Chronic Disease; Colchicine; Diagnosis, Differential; Diet Therapy; Familial Mediterranean Fever; Fever of Unknown Origin; Genetic Predisposition to Disease; Humans; Male; Pancreatitis; Recurrence; Vomiting | 2004 |
Protracted fever of unknown origin as the presenting symptom of Behçet's disease. Report of a case.
Topics: Anticoagulants; Behcet Syndrome; Chronic Disease; Colchicine; Drug Therapy, Combination; Fever of Unknown Origin; Genital Diseases, Male; Glucocorticoids; Humans; Leg; Male; Methylprednisolone; Middle Aged; Prednisolone; Stomatitis, Aphthous; Superior Vena Cava Syndrome; Ulcer; Venae Cavae; Venous Thrombosis | 2005 |
Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
Topics: Allopurinol; Anti-Inflammatory Agents; Benzbromarone; Chronic Disease; Colchicine; Drug Hypersensitivity; Gout; Humans; Uric Acid; Uricosuric Agents | 2005 |
Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure.
Topics: Aged; Anti-Inflammatory Agents; Chronic Disease; Colchicine; Conjunctiva; Conjunctival Diseases; Diclofenac; Drug Therapy, Combination; Female; Fibrosis; Glaucoma, Angle-Closure; Humans; Prednisone; Trabeculectomy; Treatment Failure | 2006 |
[Fatal Sweet syndrome associated to chronic idiopathic systemic inflammatory response syndrome].
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Biopsy; Chronic Disease; Colchicine; Fatal Outcome; Femur Head Necrosis; Hepatitis C; Humans; Male; Pancytopenia; Prednisone; Sweet Syndrome; Systemic Inflammatory Response Syndrome | 2007 |
Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.
Topics: Adult; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Diuretics; England; Family Practice; Female; Gout; Gout Suppressants; Humans; Kidney Diseases; Male; Middle Aged; Practice Guidelines as Topic; Uric Acid; Uricosuric Agents | 2007 |
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout.
Topics: Acute Disease; Chronic Disease; Colchicine; Evidence-Based Medicine; Gout; Gout Suppressants; Humans; Life Style; Recurrence | 2007 |
Treatment of acute gout in hospitalized patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colchicine; Drug Therapy, Combination; Gout; Gout Suppressants; Hospitalization; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Renal Insufficiency; Retrospective Studies | 2007 |
[A case of chronic refractory thrombocytopenia with a remarkable response to colchicine administration].
Topics: Adult; Chronic Disease; Colchicine; Female; Humans; Purpura, Thrombocytopenic; Splenectomy | 1984 |
Colchicine and chronic pseudogout.
Topics: Chondrocalcinosis; Chronic Disease; Colchicine; Female; Humans; Middle Aged | 1981 |
[Use of colchamine in periodic disease].
Topics: Adult; Chronic Disease; Colchicine; Demecolcine; Dose-Response Relationship, Drug; Drug Evaluation; Familial Mediterranean Fever; Female; Humans; Male; Middle Aged | 1980 |
Postsurgical gout.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Chronic Disease; Colchicine; Female; Fever; Humans; Incidence; Leukocytosis; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Time Factors; Uric Acid | 1995 |
Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment.
Topics: Administration, Oral; Adult; Aged; Bile; Chronic Disease; Colchicine; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Long-Term Care; Middle Aged | 1994 |
Successful treatment of chronic bullous dermatosis of childhood with colchicine.
Topics: Administration, Oral; Child, Preschool; Chronic Disease; Colchicine; Humans; Male; Skin Diseases, Vesiculobullous | 1994 |
Chronic cutaneous vasculitis in a C3-deficient patient treated with colchicine.
Topics: Adolescent; Chronic Disease; Colchicine; Complement C3; Female; Humans; Pedigree; Skin Diseases, Vascular; Vasculitis | 1993 |
The clinical patterns of arthritis in children with familial Mediterranean fever.
Topics: Acute Disease; Adolescent; Age of Onset; Arthritis; Child; Child, Preschool; Chronic Disease; Colchicine; Familial Mediterranean Fever; Female; Gout Suppressants; Humans; Infant; Male; Recurrence | 1997 |
Colchicine for large pericardial effusion.
Topics: Adult; Child, Preschool; Chronic Disease; Colchicine; Echocardiography; Female; Follow-Up Studies; Gout Suppressants; Humans; Male; Pericardial Effusion; Pericarditis; Recurrence | 1998 |
Terrien's marginal degeneration associated with erythema elevatum diutinum.
Topics: Adult; Chronic Disease; Colchicine; Conjunctiva; Conjunctival Diseases; Cornea; Corneal Ulcer; Drug Therapy, Combination; Erythema; Female; Humans; Skin Diseases, Papulosquamous; Sulfasalazine | 1998 |
Colchicine, like methylprednisolone, decreases the perilesional fibrosis secondary to a chronic brain granuloma in cats.
Topics: Aluminum Silicates; Animals; Brain Diseases; Cats; Chronic Disease; Colchicine; Collagen; Drug Synergism; Fibrosis; Granuloma; Macrophages; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelin Sheath | 1998 |
Idiopathic chronic pericardial effusion.
Topics: Anti-Inflammatory Agents; Chronic Disease; Colchicine; Follow-Up Studies; Humans; Pericardial Effusion; Pericardiectomy; Pericarditis; Secondary Prevention | 2000 |
Successful treatment of chronic Henoch-Schonlein purpura with colchicine and aspirin.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chronic Disease; Colchicine; Drug Therapy, Combination; Female; Humans; IgA Vasculitis; Leukocytes; Microtubules | 2000 |
New directions in diagnosis and treatment of pericardial disease. A project of the Taskforce on Pericardial Disease of the World Heart Federation.
Topics: Chronic Disease; Cisplatin; Clinical Trials as Topic; Colchicine; Heart Diseases; Heart Neoplasms; Humans; Medical Laboratory Science; Pericardial Effusion; Pericarditis; Pericardium; Recurrence; Thiotepa; Triamcinolone | 2000 |
[Summary of the Dutch College of General Practitioners' "Gout" Standard].
Topics: Acute Disease; Adrenal Cortex Hormones; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Benzbromarone; Chronic Disease; Colchicine; Gout; Gout Suppressants; Humans; Netherlands; Practice Guidelines as Topic; Recurrence; Uricosuric Agents | 2002 |
Chronic ascites related to encapsulating peritonitis in familial Mediterranean fever.
Topics: Adult; Ascites; Chronic Disease; Colchicine; Familial Mediterranean Fever; Female; Humans; Peritonitis | 2002 |
The specificity of IgG- and IgM-class smooth muscle antibody in the sera of patients with multiple sclerosis and active chronic hepatitis.
Topics: Animals; Antibody Specificity; Chronic Disease; Colchicine; Cytochalasin B; Embryo, Mammalian; Epithelium; Female; Fibroblasts; Fluorescent Antibody Technique; Hepatitis; Humans; Immunoglobulin G; Immunoglobulin M; Lung; Multiple Sclerosis; Muscle, Smooth; Pregnancy; Rats; Vinblastine | 1979 |
Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
Topics: Acute Disease; Allopurinol; Anti-Inflammatory Agents; Arthritis; Chronic Disease; Colchicine; Gout; Humans; Kidney Diseases; Uric Acid; Uricosuric Agents | 1979 |
Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis.
Topics: Adolescent; Calcinosis; Chronic Disease; Colchicine; Dermatomyositis; Female; Humans; Male | 1978 |
[Toxic myopathy with kidney failure as a colchicine side effect ifn familial Mediterranean fever].
Topics: Acute Kidney Injury; Adult; Amyloidosis; Biopsy; Chronic Disease; Colchicine; Diagnosis, Differential; Familial Mediterranean Fever; Female; Humans; Kidney; Kidney Diseases; Muscles; Muscular Diseases | 1992 |
The normocomplementemic urticarial vasculitis syndrome--report of a case and response to colchicine.
Topics: Chronic Disease; Colchicine; Complement System Proteins; Female; Humans; Leg Dermatoses; Middle Aged; Syndrome; Urticaria; Vasculitis | 1991 |
[Chronic human colchicine myopathy].
Topics: Aged; Chronic Disease; Colchicine; Creatine Kinase; Electromyography; Humans; Male; Microscopy, Electron; Muscles; Muscular Diseases | 1990 |
[Recurrent oral aphthosis. Its treatment with colchicine].
Topics: Adult; Chronic Disease; Colchicine; Humans; Male; Recurrence; Stomatitis, Aphthous | 1989 |
Chronic liver diseases: current therapeutic options.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Colchicine; Diagnosis, Differential; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Humans; Interferon Type I; Liver Cirrhosis, Biliary; Liver Diseases; Methotrexate | 1989 |
Colchicine therapy in primary amyloidosis of the bladder: a case report.
Topics: Adult; Amyloidosis; Biopsy; Chronic Disease; Colchicine; Cystoscopy; Hematuria; Humans; Male; Urinary Bladder; Urinary Bladder Diseases | 1989 |
[Fever of unknown origin and colchicine-sensitive amyloidosis: familial Mediterranean fever?].
Topics: Adult; Amyloidosis; Chronic Disease; Colchicine; Diagnosis, Differential; Familial Mediterranean Fever; Fever of Unknown Origin; Humans; Male; Recurrence; Time Factors | 1989 |
Cryptic adenosine triphosphatase activities in plasma membranes of CCl4-cirrhotic rats. Its modulation by changes in cholesterol/phospholipid ratios.
Topics: Acute Disease; Animals; Calcium-Transporting ATPases; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Cholesterol; Chronic Disease; Colchicine; Liver Cirrhosis; Male; Membrane Fluidity; Membrane Lipids; Membrane Proteins; Phospholipids; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase | 1985 |
Chronic human colchicine myopathy and neuropathy.
Topics: Chronic Disease; Colchicine; Humans; Muscular Diseases; Nervous System Diseases | 1988 |
Immunological studies of uveitis. 2. Immune complex containing retinal S antigen in patient with chronic intractable uveitis.
Topics: Adult; Antigen-Antibody Complex; Antigens; Arrestin; Chronic Disease; Colchicine; Drug Resistance; Eye Proteins; Fluorescein Angiography; Humans; Macular Edema; Male; Phlebitis; Retinal Vessels; Uveitis | 1986 |
Cutaneous leukocytoclastic vasculitis: clinical experience in 44 patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Chronic Disease; Colchicine; Drug Evaluation; Drug Synergism; Female; Humans; Leukocytes; Male; Middle Aged; Recurrence; Retrospective Studies; Skin; Vasculitis; Vasculitis, Leukocytoclastic, Cutaneous | 1987 |
[Destructive arthropathy in familial Mediterranean fever].
Topics: Adult; Armenia; Arthrography; Chronic Disease; Colchicine; Familial Mediterranean Fever; Humans; Joint Diseases; Male | 1986 |
Chronic human colchicine neuropathy and myopathy.
Topics: Adult; Axons; Chronic Disease; Colchicine; Female; Humans; Muscular Diseases; Nervous System Diseases | 1986 |
"Interstitial pathology': an overview of the chronic interstitial lung disorders.
Topics: Administration, Oral; Adrenal Cortex Hormones; Chronic Disease; Colchicine; Collagen Diseases; Cyclophosphamide; Cyclosporins; Humans; Infusions, Parenteral; Pneumoconiosis; Pulmonary Alveoli; Pulmonary Fibrosis; Sarcoidosis | 1985 |
[Agranulocytosis with erythroderma following treatment of gout with Colcemid].
Topics: Agranulocytosis; Chronic Disease; Colchicine; Dermatitis, Exfoliative; Gout; Humans; Male; Middle Aged | 1971 |
Management of chronic and recurrent gout.
Topics: Adrenocorticotropic Hormone; Allopurinol; Chronic Disease; Colchicine; Dexamethasone; Diet Therapy; Gout; Humans; Indomethacin; Lidocaine; Phenylbutazone; Prednisolone; Probenecid; Recurrence; Synovial Fluid; Uric Acid | 1971 |
[Modern therapy of gout].
Topics: Acute Disease; Chronic Disease; Colchicine; Diet, Reducing; Female; Gout; Humans; Indomethacin; Kidney Calculi; Male; Phenylbutazone; Prednisolone; Probenecid; Pyelonephritis; Sex Factors | 1972 |
[Current etiopathogenetic and therapeutic views concerning gout and hyperuremic syndromes].
Topics: Acute Disease; Aged; Antimetabolites; Chronic Disease; Colchicine; Female; Genetic Code; Gout; Humans; Indomethacin; Male; Middle Aged; Phenylbutazone; Purines; RNA, Messenger; Syndrome; Uric Acid; Uricosuric Agents | 1973 |
[Gout--based on 110 cases. II].
Topics: Acute Disease; Allopurinol; Chronic Disease; Colchicine; Diabetes Complications; Gout; Humans; Hypertension; Indomethacin; Purines; Pyrazoles; Uricosuric Agents | 1968 |
Pathogenesis and medical management of chronic gouty arthritis.
Topics: Allopurinol; Chronic Disease; Colchicine; Gout; Humans; Joints; Kidney; Probenecid; Sulfinpyrazone; Uric Acid | 1970 |
Long-term treatment of gout with "allopurinol".
Topics: Allopurinol; Chronic Disease; Colchicine; Colorimetry; Female; Gout; Humans; Male; Purines; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1968 |
Management of gout.
Topics: Acute Disease; Allopurinol; Chronic Disease; Colchicine; Gout; Humans; Indomethacin; Metabolic Diseases; Phenylbutazone; Salicylates; Uric Acid; Uricosuric Agents | 1969 |